BeOne Medicines (ONC) Total Debt Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 6.94% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 50.25% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.07% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 30.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.25% |
| Dec 31, 2025 | 69.54% |
| Sep 30, 2025 | 36.35% |
| Jun 30, 2025 | 19.03% |
| Mar 31, 2025 | 14.89% |
| Dec 31, 2024 | 17.37% |
| Sep 30, 2024 | 17.79% |
| Jun 30, 2024 | 18.09% |
| Mar 31, 2024 | 19.71% |
| Dec 31, 2023 | 19.54% |
| Sep 30, 2023 | 223.45% |
| Jun 30, 2023 | 50.00% |
| Mar 31, 2023 | 73.65% |
| Dec 31, 2022 | 35.91% |
| Sep 30, 2022 | 62.45% |
| Jun 30, 2022 | 82.42% |
| Mar 31, 2022 | 54.82% |
| Dec 31, 2021 | 58.67% |
| Sep 30, 2021 | 135.01% |
| Jun 30, 2021 | 58.45% |
| Mar 31, 2021 | 53.89% |
| Dec 31, 2020 | 49.41% |
| Sep 30, 2020 | -4.53% |
| Jun 30, 2020 | 119.12% |
| Mar 31, 2020 | 67.31% |
| Dec 31, 2019 | 68.92% |
| Sep 30, 2019 | 103.28% |
| Jun 30, 2019 | 106.72% |
| Mar 31, 2019 | 197.80% |
| Dec 31, 2018 | 96.46% |